Related Experiment Videos
Caeruloplasmin isoforms in Wilson's disease in neonates
G F Chowrimootoo1, H Scowcroft, C A Seymour
1Division of Cardiological Sciences (Metabolic Medicine), St George's Hospital Medical School, London.
Summary
Caeruloplasmin isoforms in cord blood may help diagnose Wilson's disease in newborns. This method identifies reduced plasma isoforms, potentially aiding early detection of this genetic liver disorder.
Area of Science:
- Biochemistry
- Neonatal Medicine
- Genetics
Background:
- Wilson's disease is a genetic disorder affecting copper metabolism.
- Early diagnosis in neonates is crucial for effective management.
- Current diagnostic methods may have limitations in early detection.
Purpose of the Study:
- To investigate the utility of caeruloplasmin isoforms in cord blood for neonatal Wilson's disease diagnosis.
- To establish a potential biomarker for early Wilson's disease detection.
Main Methods:
- Serum caeruloplasmin isoforms were analyzed from cord blood using SDS-PAGE and western blotting.
- Total caeruloplasmin concentrations were quantified by nephelometry.
- Caeruloplasmin oxidase activity was measured using p-nitrophenyldiamine.
Main Results:
- Plasma caeruloplasmin isoform was significantly reduced or absent in neonates with Wilson's disease.
- Healthy neonates and those with Wilson's disease showed reduced biliary isoforms.
- Total caeruloplasmin concentrations were generally lower in neonates.
Conclusions:
- Caeruloplasmin isoforms in cord blood show promise as a diagnostic marker for neonatal Wilson's disease.
- This isoform analysis could facilitate earlier identification and intervention for Wilson's disease.